|4Jul 25, 11:31 AM ET

Caplan Vered 4

4 · Orgenesis Inc. · Filed Jul 25, 2024

Insider Transaction Report

Form 4
Period: 2024-07-23
Caplan Vered
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-07-23+85,00085,000 total
    Exercise: $0.64Exp: 2034-07-22Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]Equal vesting over the next eight quarters with the vesting of the first 10,625 options commencing on September 30, 2024, subject to the reporting person's continued service through the applicable vesting dates.

Documents

1 file
  • 4
    ownership.xmlPrimary